|
CN112079818A
|
|
Preparation method of erdamitinib intermediate
|
|
CN112047929A
|
|
Preparation method of 3- (1-methyl-1H-pyrazol-4-yl) -6-quinoxalinamine
|
|
CN112125888A
|
|
Preparation method of 3- (1-methyl-1H-pyrazol-4-yl) -6-quinoxalinamine
|
|
CN112079817A
|
|
Preparation method of ervatinib intermediate
|
|
CN112125889A
|
|
Preparation method of 7-bromo-2- (1-methyl-1H-pyrazol-4-yl) quinoxaline
|
|
CN112079816A
|
|
Preparation method of 7-bromo-2- (1-methyl-1H-pyrazol-4-yl) quinoxaline
|
|
CN111793039A
|
|
Preparation method of dortinode
|
|
CN111675675A
|
|
Preparation method of dortinode
|
|
CN111635404A
|
|
Preparation method of dovinisine
|
|
CN111662247A
|
|
Synthesis method of dortinode
|
|
CN111675710A
|
|
Preparation method of dovinisine
|
|
CN111574540A
|
|
Preparation method of degotatinib
|
|
CN111560021A
|
|
Degaotinib intermediate and preparation method thereof
|
|
CN111606929A
|
|
Preparation method of degotatinib
|
|
CN111732595A
|
|
Degatinib intermediate and preparation method thereof
|
|
CN111732583A
|
|
Preparation method of Apinerocine
|
|
CN111620863A
|
|
Preparation method of atrabopag
|
|
CN111592531A
|
|
Preparation method of furosemide
|
|
CN111732582A
|
|
Preparation method of atrabopag
|
|
CN111620860A
|
|
Preparation method of furosemide
|
